Eli Lilly (LLY) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Eli Lilly (LLY) quarterly earnings & revenue
Eli Lilly (LLY) reported revenue of $19.80B for Q1 2026, up 55.5% year-over-year, with net income of $7.40B and diluted EPS of $8.26.
Over the last four reported quarters, Eli Lilly generated $72.25B in revenue and $25.27B in net income.
Eli Lilly's next earnings report is scheduled for August 5, 2026 before market open; analysts estimate EPS of $8.82.
Eli Lilly quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $19.80B | +55.5% | $7.40B | $8.26 |
| Q4 2025 | $19.29B | +42.6% | $6.64B | $7.39 |
| Q3 2025 | $17.60B | +53.9% | $5.58B | $6.21 |
| Q2 2025 | $15.56B | +37.6% | $5.66B | $6.29 |
| Q1 2025 | $12.73B | +45.2% | $2.76B | $3.06 |
| Q4 2024 | $13.53B | +44.7% | $4.41B | $4.88 |
| Q3 2024 | $11.44B | +20.4% | $970.30M | $1.07 |
| Q2 2024 | $11.30B | +36.0% | $2.97B | $3.28 |
Eli Lilly (LLY) — frequently asked questions
When does Eli Lilly (LLY) report earnings next?
Eli Lilly is expected to report earnings on August 5, 2026 before market open. Analysts estimate EPS of $8.82.
What was LLY's revenue last quarter?
Eli Lilly reported revenue of $19.80B in Q1 2026, up 55.5% from the same quarter a year earlier.
What was LLY's EPS last quarter?
Eli Lilly reported diluted EPS of $8.26 in Q1 2026.
Is Eli Lilly profitable?
Eli Lilly is currently profitable, with $25.27B in net income over the last four reported quarters.
Compare with other Healthcare companies: Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK) · Novartis (NVS)